These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24724562)

  • 1. Passive lipoidal diffusion and carrier-mediated cell uptake are both important mechanisms of membrane permeation in drug disposition.
    Smith D; Artursson P; Avdeef A; Di L; Ecker GF; Faller B; Houston JB; Kansy M; Kerns EH; Krämer SD; Lennernäs H; van de Waterbeemd H; Sugano K; Testa B
    Mol Pharm; 2014 Jun; 11(6):1727-38. PubMed ID: 24724562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based approach to assess passive diffusion and carrier-mediated drug transport.
    Di L; Artursson P; Avdeef A; Ecker GF; Faller B; Fischer H; Houston JB; Kansy M; Kerns EH; Krämer SD; Lennernäs H; Sugano K
    Drug Discov Today; 2012 Aug; 17(15-16):905-12. PubMed ID: 22507594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carrier-mediated cellular uptake of pharmaceutical drugs: an exception or the rule?
    Dobson PD; Kell DB
    Nat Rev Drug Discov; 2008 Mar; 7(3):205-20. PubMed ID: 18309312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coexistence of passive and carrier-mediated processes in drug transport.
    Sugano K; Kansy M; Artursson P; Avdeef A; Bendels S; Di L; Ecker GF; Faller B; Fischer H; Gerebtzoff G; Lennernaes H; Senner F
    Nat Rev Drug Discov; 2010 Aug; 9(8):597-614. PubMed ID: 20671764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards a unified model of passive drug permeation I: origins of the unstirred water layer with applications to ionic permeation.
    Ghosh A; Scott DO; Maurer TS
    Eur J Pharm Sci; 2014 Feb; 52():109-24. PubMed ID: 24211511
    [TBL] [Abstract][Full Text] [Related]  

  • 6. What would be the observable consequences if phospholipid bilayer diffusion of drugs into cells is negligible?
    Kell DB
    Trends Pharmacol Sci; 2015 Jan; 36(1):15-21. PubMed ID: 25458537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Absorption of poorly water soluble drugs subject to apical efflux using phospholipids as solubilizers in the Caco-2 cell model.
    Kapitza SB; Michel BR; van Hoogevest P; Leigh ML; Imanidis G
    Eur J Pharm Biopharm; 2007 Apr; 66(1):146-58. PubMed ID: 17071065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical drug transport: the issues and the implications that it is essentially carrier-mediated only.
    Kell DB; Dobson PD; Oliver SG
    Drug Discov Today; 2011 Aug; 16(15-16):704-14. PubMed ID: 21624498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of P-glycoprotein-mediated multidrug resistance by acceleration of passive drug permeation across the plasma membrane.
    Regev R; Katzir H; Yeheskely-Hayon D; Eytan GD
    FEBS J; 2007 Dec; 274(23):6204-14. PubMed ID: 17986257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of Passive Diffusion, Transporters, and Membrane Trafficking-Mediated Processes in Cellular Drug Transport.
    Cocucci E; Kim JY; Bai Y; Pabla N
    Clin Pharmacol Ther; 2017 Jan; 101(1):121-129. PubMed ID: 27804130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Passive drug permeation through membranes and cellular distribution.
    Scott DO; Ghosh A; Di L; Maurer TS
    Pharmacol Res; 2017 Mar; 117():94-102. PubMed ID: 27890815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Drug permeation through synthetic lipid membranes. Part 10: The effects of diffusion layers on the permeation process (author's transl)].
    Fürst W; Neubert R; Reppel L
    Pharmazie; 1980 Feb; 35(2):106-9. PubMed ID: 7384178
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporters--the view from industry.
    Kohl C
    Chem Biodivers; 2009 Nov; 6(11):1988-99. PubMed ID: 19937835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol enhanced permeation in model membranes. Part I. Thermodynamic and kinetic analyses of membrane permeation.
    Oliveira G; Beezer AE; Hadgraft J; Lane ME
    Int J Pharm; 2010 Jun; 393(1-2):61-7. PubMed ID: 20371274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transport mechanisms of flavanone aglycones across Caco-2 cell monolayers and artificial PAMPA membranes.
    Kobayashi S; Nagai T; Konishi Y; Tanabe S; Morimoto K; Ogihara T
    J Pharm Pharmacol; 2012 Jan; 64(1):52-60. PubMed ID: 22150672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Theoretical investigation of passive intestinal membrane permeability using Monte Carlo method to generate drug-like molecule population.
    Sugano K
    Int J Pharm; 2009 May; 373(1-2):55-61. PubMed ID: 19429288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SC lipid model membranes designed for studying impact of ceramide species on drug diffusion and permeation--part II: diffusion and permeation of model drugs.
    Ochalek M; Podhaisky H; Ruettinger HH; Wohlrab J; Neubert RH
    Eur J Pharm Biopharm; 2012 Oct; 82(2):360-6. PubMed ID: 22750439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does transbilayer diffusion have a role in membrane transport of drugs?
    Balaz S
    Drug Discov Today; 2012 Oct; 17(19-20):1079-87. PubMed ID: 22705388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Commentary: nonspecific protein binding versus membrane partitioning: it is not just semantics.
    Nagar S; Korzekwa K
    Drug Metab Dispos; 2012 Sep; 40(9):1649-52. PubMed ID: 22711748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prediction of oral drug absorption in humans by theoretical passive absorption model.
    Obata K; Sugano K; Saitoh R; Higashida A; Nabuchi Y; Machida M; Aso Y
    Int J Pharm; 2005 Apr; 293(1-2):183-92. PubMed ID: 15778056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.